[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT2331057T - Composições e métodos para modulação da pigmentação da pele - Google Patents

Composições e métodos para modulação da pigmentação da pele

Info

Publication number
PT2331057T
PT2331057T PT09736640T PT09736640T PT2331057T PT 2331057 T PT2331057 T PT 2331057T PT 09736640 T PT09736640 T PT 09736640T PT 09736640 T PT09736640 T PT 09736640T PT 2331057 T PT2331057 T PT 2331057T
Authority
PT
Portugal
Prior art keywords
compositions
methods
skin pigmentation
modulating skin
modulating
Prior art date
Application number
PT09736640T
Other languages
English (en)
Inventor
Kumar Singh Suman
Tobin Desmond John
Original Assignee
Univ Bradford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41718311&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2331057(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0816507.8A external-priority patent/GB0816507D0/en
Priority claimed from GB0908498A external-priority patent/GB0908498D0/en
Application filed by Univ Bradford filed Critical Univ Bradford
Publication of PT2331057T publication Critical patent/PT2331057T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
PT09736640T 2008-09-10 2009-09-08 Composições e métodos para modulação da pigmentação da pele PT2331057T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0816507.8A GB0816507D0 (en) 2008-09-10 2008-09-10 Product and method
GB0908498A GB0908498D0 (en) 2009-05-18 2009-05-18 Compositions and methods

Publications (1)

Publication Number Publication Date
PT2331057T true PT2331057T (pt) 2019-06-25

Family

ID=41718311

Family Applications (1)

Application Number Title Priority Date Filing Date
PT09736640T PT2331057T (pt) 2008-09-10 2009-09-08 Composições e métodos para modulação da pigmentação da pele

Country Status (9)

Country Link
US (1) US8883725B2 (pt)
EP (1) EP2331057B1 (pt)
JP (1) JP5773872B2 (pt)
CN (1) CN102209522B (pt)
AU (1) AU2009290625B2 (pt)
DK (1) DK2331057T3 (pt)
ES (1) ES2727627T3 (pt)
PT (1) PT2331057T (pt)
WO (1) WO2010029343A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012060323A1 (ja) 2010-11-01 2012-05-10 花王株式会社 皮膚及び毛髪色制御因子
JP2015519880A (ja) * 2012-03-30 2015-07-16 ザ プロクター アンド ギャンブルカンパニー 摂動因子及び皮膚の色素沈着過剰状態に関連する遺伝子間の関連性を特定するためのシステム
US8927517B2 (en) * 2012-04-27 2015-01-06 Kao Corporation Factors controlling skin and hair color
KR102348045B1 (ko) 2015-02-27 2022-01-11 (주)아모레퍼시픽 미백성분의 부작용을 예측하는 방법
CN110092816B (zh) * 2018-01-29 2023-08-01 上海市第一人民医院 预防和治疗纤维化的小分子多肽及其应用
GB201804355D0 (en) * 2018-03-19 2018-05-02 Imperial Innovations Ltd Wound treatment
WO2020000470A1 (zh) * 2018-06-29 2020-01-02 深圳市博奥康生物科技有限公司 促进cdc42蛋白过表达的重组载体及其构建方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381292A (en) * 1980-11-14 1983-04-26 The Board Of Trustees Of The Leland Stanford Jr. University Anti-human T-lymphocyte monoclonal antibody
US4451570A (en) * 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4618577A (en) * 1983-02-09 1986-10-21 The Regents Of The University Of California Human-human hybridoma, CLNH5
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CA2386270A1 (en) 1999-10-15 2001-04-26 University Of Massachusetts Rna interference pathway genes as tools for targeted genetic interference
US6165790A (en) * 1999-11-03 2000-12-26 Isis Pharmaceuticals Inc. Antisense modulation of PI3 kinase p55 gamma expression
WO2002099037A2 (en) * 2001-06-01 2002-12-12 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
WO2003086313A2 (en) 2002-04-12 2003-10-23 Trustees Of Boston University Methods for lightening skin and hair
WO2006105359A2 (en) * 2005-03-30 2006-10-05 Wyeth Methods for stimulating hair growth by administering bmps
FR2904532B1 (fr) * 2006-08-03 2012-10-19 Soc Extraction Principes Actif Composition dermatologique et/ou cosmetique contenant des polypeptides ou des peptides
US20100143289A1 (en) * 2006-12-19 2010-06-10 Michael Cohen Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
BRPI0811102A2 (pt) * 2007-05-15 2014-09-23 Puretech Ventures Métodos e composições para tratar condições de pele
WO2009114180A1 (en) * 2008-03-13 2009-09-17 The General Hospital Corporation Inhibitors of the bmp signaling pathway

Also Published As

Publication number Publication date
JP2012501639A (ja) 2012-01-26
EP2331057A2 (en) 2011-06-15
AU2009290625B2 (en) 2014-12-11
CN102209522A (zh) 2011-10-05
JP5773872B2 (ja) 2015-09-02
ES2727627T3 (es) 2019-10-17
US20110206625A1 (en) 2011-08-25
EP2331057B1 (en) 2019-03-20
CN102209522B (zh) 2016-04-06
WO2010029343A2 (en) 2010-03-18
DK2331057T3 (da) 2019-06-17
US8883725B2 (en) 2014-11-11
WO2010029343A3 (en) 2010-06-10
AU2009290625A1 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
IL208458A0 (en) Compositions and methods for skin care
EP2254546A4 (en) TOPICAL COMPOSITIONS AND METHODS FOR LAUNDERING THE SKIN
EP2192889A4 (en) COSMETIC PROCESSES AND COMPOSITIONS FOR THE REPAIR OF HUMAN SKIN
IL202015A0 (en) Methods and compositions for treating skin conditions
EP2347789A4 (en) DERMATOLOGICAL STIMULATOR
EP2498772A4 (en) COMPOSITIONS AND METHODS FOR IMPROVING SKIN APPEARANCE
HK1180239A1 (zh) 用於組織礦化的微膠囊化組合物和方法
EP2314278A4 (en) HAIR TREATMENT COMPOSITION
EP2461765A4 (en) COSMETIC REJUVENATION OF THE SKIN
EP2391208A4 (en) COMPOSITIONS FOR THE TREATMENT OF NAILS AND SKIN
EP2127634A4 (en) COMPOSITION FOR SKIN OR HAIR
EP2544655A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN
PT2129680E (pt) Composições combinadas de gancho de cabelo e antissentido e métodos para modulação da expressão
EP2168568A4 (en) SKIN COSMETICS
EP2349305A4 (en) PHYTOCHEMICAL COMPOSITIONS AND METHOD FOR AMP-KINASE ACTIVATION
EP2600824A4 (en) COSMETIC COMPOSITION FOR PREVENTING SKIN AGING
EP2490542A4 (en) DERMATOLOGICAL AND COSMETIC COMPOSITIONS
HK1146580A1 (en) Skin cosmetic
GB0719202D0 (en) Compositions and methods for the skin and hair
PT2331057T (pt) Composições e métodos para modulação da pigmentação da pele
EP2275113A4 (en) MEDIUM FOR IMPROVING SKIN CIRCULATION AND MEDIUM FOR INCREASING SKIN TEMPERATURE
GB0808723D0 (en) Cosmetic formulation
ZA201100108B (en) Skin lightening compositions comprising co2 extracts
ZA201103771B (en) Hypoallergenic dermatological composition
PL2165698T3 (pl) Kompozycja kosmetyczna przeznaczona do pielęgnacji uszkodzonej skóry